Abstract:Twenty-five to thirty percent of patients with node-negative breast cancer are expected to relapse following surgery, therefore great efforts have been made to identify new prognostic markers that could be useful in defining patients for additional therapy. The expression of MMP-2 and MMP-9 has been associated with high potential of metastasis in several human carcinomas including breast cancer. In the present study we examined the prognostic value of immunoreactive MMP-2/MMP-9 protein in 270 consecutive lymph node negative cases who received radical mastectomy or modified radical mastectomy. Among the patients, 211 cases received adjuvant endocrine therapy and/or adjuvant chemotherapy. Using immunohistochemical assay, we found that 56.7% of the resected tumors were positive for MMP-2 whereas 59.6% of the samples were positive for MMP-9. χ 2 test demonstrated a significant direct association between MMP-2 and MMP-9 ( p < 0.001); positive immunostaining of MMP-2 was significantly related to higher tumor grade ( p < 0.001) and larger tumor size ( p =0.012); positive immunostaining of MMP-9 was significantly related to higher tumor grade ( p =0.002). In univariate analysis, using Cox-proportional hazard model we found MMP-2, MMP-9 and the co-expression of MMPs (MMP2/MMP9) were significantly associated with patients' relapse free survival ( p =0.016, 0.015 and 0.013 respectively) but not overall survival ( p =0.122, 0.320 and 0.091 respectively). Log-rank test also showed that MMP-2, MMP-9 or the co-expression of MMP2/MMP9 was unfavorable prognostic factor for relapse free survival but not overall survival. In subgroup analysis, we found MMPs were more prognostic for patients with no adjuvant treatment than for patients with adjuvant therapy. In multivariate analysis, using Cox-proportional hazard model we found co-expression of MMPs, larger tumor size and higher tumor grade were unfavorable for relapse free survival ( p =0.038, 0.007 and 0.015 for each). We concluded that MMP-2 and MMP-2 are unfavorable prognostic factors in breast cancer patients. They might be potential predictive factor for adjuvant systemic therapy. The co-expression of MMP-2 and MMP-9 has significantly prognostic value in node-negative patients.

Matrix Metalloproteinase 9 for Evaluating Invasiveness and Recurrence in Pituitary Adenoma Patients: A Meta-analysis

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Expressions of Ki-67 and MMP-9 and Their Relationship with the Invasiveness in Pituitary Adenomas

Expressions of Focal Adhesion Kinase and Matrix Metalloproteinase-9 in Pituitary Adenomas

Prognostic Value of Matrix Metalloproteinase 9 Expression in Patients with Non-Small Cell Lung Cancer

Prognostic Value of Matrix Metalloproteinases (MMP-2 and MMP-9) in Patients with Lymph Node-Negative Breast Carcinoma

The Study of the Correlations Between MRI and Expression of MMP 9 in Invasive Pituitary Adenomas

Matrix Metalloproteinase-9 As a Prognostic Factor in Gastric Cancer: a Meta-Analysis.

The expression level and correlation of MMP-9 and IL-17 in pituitary tumor tissue

Prognostic Value of MMP9 Activity Level in Resected Stage I B Lung Adenocarcinoma.

Diagnostic Value of Matrix Metalloproteinase 9 for Malignant Pleural Effusion: A Meta Analysis

The Significance of MMP-9 over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma after Curative Resection.

Immunohistochemical Analysis of Matrix Metalloproteinase-9 Predicts Papillary Thyroid Carcinoma Prognosis

Clinical significance of MMP-9 overexpression in endometrial cancer: A PRISMA-compliant meta-analysis

Prognostic significance of matrix metalloproteinase-2 in gynecological cancer: a systemic review of the literature and meta-analysis.

The Expression of Interleukin (IL)-17 and IL-17 Receptor and MMP-9 in Human Pituitary Adenomas.

Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer

Expressions of Matrix Metalloproteinase-2 and -9 in Pancreatic Carcinoma and Its Significance

Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.

Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis